http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2018874-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8092b9ec2a531edd1f796a5b8cb01e4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 1999-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f364eceba693961b0eba611fca91788
publicationDate 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2018874-A3
titleOfInvention Pharmaceutical compositions for the prevention and treatment of central nervous system disorders comprising a nicotinic compound and an acetylcholinesterase inhibitor
abstract A pharmaceutical composition comprising a pharmaceutically effective amount of at least two components, one of those components being a nicotinic agonist and one of those components being an acetylcholinesterase inhibitor, wherein the acetylcholinesterase inhibitor is donepezil.
priorityDate 1998-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5726316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5597919-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594

Total number of triples: 39.